TPO and Graves disease: Methimazole is the preferred therapy for adolescent hyperthyroidism, particularly in Graves’ disease, as it targets thyroid peroxidase to inhibit iodine oxidation and prevent the synthesis of thyroxine (T4) and triiodothyronine (T3); however, it does not deactivate circulating hormones (1).